Michael Watkins, of Harrison, Arkansas, as Business Manager for the Midwest and Southeast. Mr. Watkins was most recently with Novartis Animal Health and has a degree in Marketing Management from the University of Arkansas. Mr. Watkins will manage the growth of probiotic and inoculant accounts as well as key national accounts.
Alex Turney as Business Development Director for Australia and New Zealand. Alex will be responsible for the development of Lallemand Animal Nutrition product portfolio in both Australia and New Zealand, and for the management of the company's sales and technical support teams on these territories. Before joining Lallemand, Alex Turney was Business Unit Manager Intensive Livestock for Elanco Animal Health, Australia. He will operate from Lallemand's Australian subsidiary Agrig8, acquired in June 2010 and headquartered in Maroochydore, Queensland. Alex Turney has a degree in applied science from Massey University in New Zealand and has been with Elanco for the past 5 years. Prior to joining Elanco he worked for Adisseo for 7 years, managing their vitamin and enzymes portfolio in Australia and New Zealand.
Lallemand, Inc. is a privately held Canadian company specialized in yeast, bacteria and yeast derivatives, for animal nutrition, baking, winemaking and pharmaceutical industries. Lallemand is the only major supplier of yeast and bacteria that is a primary producer of both, and is a recognized leader in screening for optimized microbial strains for feed, food and ethanol applications. 11.30.2011